eyediseases
People on the blockbuster weight-loss and diabetes drugs Wegovy and Ozempic may be at higher risk of one-eye blindness from a rare eye condition, new research finds. The study, published in the journal JAMA Ophthalmology, included the medical records of about 17,000 people over six years. It found that patients with diabetes who were prescribed semaglutide, which is marketed as Wegovy and Ozempic, were about four times more likely to be diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION), an eye condition that is painless but cannot be treated or cured. Meanwhile, overweigh...
Euronews (English)
The "sleep hormone" and common supplement melatonin could be linked to a decreased risk of age-related macular degeneration (AMD). AMD is a progressive eye condition affecting the macula, a small area near the centre of the retina, and can blur your central vision. There is no definitive cure for AMD but several treatments can help manage the condition and slow its progression. A team of researchers from the Case Western Reserve University School of Medicine and the Cole Eye Institute both based in the US looked at the health data of over 200,000 people, some at an early stage of the disease a...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら